Scoop: Palmetto takes check-in bids as sponsors circle

Carousel Capital-backed Palmetto Infusion recently took check-in bids from a handful of sponsors including GTCR, sources familiar tell Axios Pro.

Inside the room: With about $30 million in EBITDA, Palmetto is angling for a $500 million valuation, two sources say.